Mp-470553-002 Economic Evaluation of Insertable Cardiac Monitors Compared to Short-Term Monitoring to Detect Atrial Fibrillation After Stroke Attributed to Large-Artery or Small-Vessel Disease

Detection of atrial fibrillation (AF) in patients with stroke is crucial for decision-making about onward secondary stroke prevention with direct oral anticoagulant (DOAC) therapy. The randomized STROKE AF trial evaluated patients with ischemic stroke attributed to large-artery or small-vessel disease (LAD/SVD) and determined insertable cardiac monitors (ICMs) to be more likely to detect AF than standard of care (SoC) using intermittent external ECG monitors.